Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Comparison of SureSelect and Nextera Exome Capture Performance in Single-Cell Sequencing.

Huss WJ, Hu Q, Glenn ST, Gangavarapu KJ, Wang J, Luce JD, Quinn PK, Brese EA, Zhan F, Conroy JM, Paragh G, Foster BA, Morrison CD, Liu S, Wei L.

Hum Hered. 2019 Jan 22;83(3):153-162. doi: 10.1159/000490506. [Epub ahead of print]

PMID:
30669152
2.

Developing a patient-centered outcome for targeting early childhood obesity across multiple stakeholders.

Foster BA, Winkler P, Weinstein K, Parra-Medina D.

BMC Obes. 2018 Dec 3;5:39. doi: 10.1186/s40608-018-0216-2. eCollection 2018.

3.

Clinical Practice Guideline: Maintenance Intravenous Fluids in Children.

Feld LG, Neuspiel DR, Foster BA, Leu MG, Garber MD, Austin K, Basu RK, Conway EE Jr, Fehr JJ, Hawkins C, Kaplan RL, Rowe EV, Waseem M, Moritz ML; SUBCOMMITTEE ON FLUID AND ELECTROLYTE THERAPY.

Pediatrics. 2018 Dec;142(6). pii: e20183083. doi: 10.1542/peds.2018-3083.

PMID:
30478247
4.

Hepatic and renal toxicity and associated factors among HIV-infected children on antiretroviral therapy: a prospective cohort study.

Tadesse BT, Foster BA, Kabeta A, Ayalew F, H/Meskel G, Jerene D, Makonnen E, Aklillu E.

HIV Med. 2019 Feb;20(2):147-156. doi: 10.1111/hiv.12693. Epub 2018 Nov 26.

PMID:
30474906
5.

Moderating Effects of Components of Resilience on Obesity Across Income Strata in the National Survey of Children's Health.

Foster BA, Weinstein K.

Acad Pediatr. 2019 Jan - Feb;19(1):58-66. doi: 10.1016/j.acap.2018.08.012. Epub 2018 Aug 30.

PMID:
30172917
6.

Identification and Characterization of Families That Are Positively Deviant for Childhood Obesity in a Latino Population: A Case-Control Study.

Foster BA, Aquino CA, Mejia S, Turner BJ, Singhal A.

J Obes. 2018 Jun 19;2018:9285164. doi: 10.1155/2018/9285164. eCollection 2018.

7.
8.

High Levels of Dual-Class Drug Resistance in HIV-Infected Children Failing First-Line Antiretroviral Therapy in Southern Ethiopia.

Tadesse BT, Kinloch NN, Baraki B, Lapointe HR, Cobarrubias KD, Brockman MA, Brumme CJ, Foster BA, Jerene D, Makonnen E, Aklillu E, Brumme ZL.

Viruses. 2018 Feb 1;10(2). pii: E60. doi: 10.3390/v10020060.

9.

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model.

Affronti HC, Long MD, Rosario SR, Gillard BM, Karasik E, Boerlin CS, Pellerite AJ, Foster BA, Attwood K, Pili R, Wilton JH, Campbell MJ, Smiraglia DJ.

Oncotarget. 2017 Oct 20;8(61):103758-103774. doi: 10.18632/oncotarget.21911. eCollection 2017 Nov 28.

10.

Capacity-oriented approaches to developing childhood obesity interventions: a systematic review.

Foster BA, Fu E, Bendiks N, Gaspard CS, Sharifi M.

Clin Obes. 2018 Apr;8(2):95-104. doi: 10.1111/cob.12234. Epub 2017 Dec 10. Review.

11.

Characterization of prostate cancer cell progression in zebrafish xenograft model.

Xu W, Foster BA, Richards M, Bondioli KR, Shah G, Green CC.

Int J Oncol. 2018 Jan;52(1):252-260. doi: 10.3892/ijo.2017.4189. Epub 2017 Nov 6.

12.

Characterization of the Stool Microbiome in Hispanic Preschool Children by Weight Status and Time.

Hollister EB, Foster BA, Dahdouli M, Ramirez J, Lai Z.

Child Obes. 2018 Feb/Mar;14(2):122-130. doi: 10.1089/chi.2017.0122. Epub 2017 Oct 13.

PMID:
29028448
13.

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.

Mett V, Komarova EA, Greene K, Bespalov I, Brackett C, Gillard B, Gleiberman AS, Toshkov IA, Aygün-Sunar S, Johnson C, Karasik E, Bapardekar-Nair M, Kurnasov OV, Osterman AL, Stanhope-Baker PS, Morrison C, Moser MT, Foster BA, Gudkov AV.

Oncogene. 2018 Jan 25;37(4):439-449. doi: 10.1038/onc.2017.346. Epub 2017 Oct 2.

14.

Parent Preferences for Shared Decision-making in Acute Versus Chronic Illness.

Tom DM, Aquino C, Arredondo AR, Foster BA.

Hosp Pediatr. 2017 Oct;7(10):602-609. doi: 10.1542/hpeds.2017-0049.

15.

LSD1 dual function in mediating epigenetic corruption of the vitamin D signaling in prostate cancer.

Battaglia S, Karasik E, Gillard B, Williams J, Winchester T, Moser MT, Smiraglia DJ, Foster BA.

Clin Epigenetics. 2017 Aug 11;9:82. doi: 10.1186/s13148-017-0382-y. eCollection 2017.

16.

Trends and Disparities in the Prevalence of Childhood Obesity in South Texas between 2009 and 2015.

Foster BA, Maness TM, Aquino CA.

J Obes. 2017;2017:1424968. doi: 10.1155/2017/1424968. Epub 2017 Jul 18.

17.

Randomized Controlled Trial of DHA Supplementation during Pregnancy: Child Adiposity Outcomes.

Foster BA, Escaname E, Powell TL, Larsen B, Siddiqui SK, Menchaca J, Aquino C, Ramamurthy R, Hale DE.

Nutrients. 2017 Jun 2;9(6). pii: E566. doi: 10.3390/nu9060566.

18.

Current Update of Patient-Derived Xenograft Model for Translational Breast Cancer Research.

Kawaguchi T, Foster BA, Young J, Takabe K.

J Mammary Gland Biol Neoplasia. 2017 Jun;22(2):131-139. doi: 10.1007/s10911-017-9378-7. Epub 2017 Apr 27. Review.

19.

Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia.

Tadesse BT, Foster BA, Jerene D, Ruff A.

BMJ Open. 2017 Feb 28;7(2):e013528. doi: 10.1136/bmjopen-2016-013528.

20.
21.

A Pilot Study of Parent Mentors for Early Childhood Obesity.

Foster BA, Aquino CA, Gil M, Gelfond JA, Hale DE.

J Obes. 2016;2016:2609504. doi: 10.1155/2016/2609504. Epub 2016 Jun 9.

22.

The uses of medical oaths in the twenty-first century.

Crawshaw RS, Foster BA, Iles-Shih M, Stull J.

Pharos Alpha Omega Alpha Honor Med Soc. 2016 Spring;79(2):20-5. No abstract available.

PMID:
27328533
23.

The essential role of methylthioadenosine phosphorylase in prostate cancer.

Bistulfi G, Affronti HC, Foster BA, Karasik E, Gillard B, Morrison C, Mohler J, Phillips JG, Smiraglia DJ.

Oncotarget. 2016 Mar 22;7(12):14380-93. doi: 10.18632/oncotarget.7486.

24.

Metastatic phenotype in CWR22 prostate cancer xenograft following castration.

Seedhouse SJ, Affronti HC, Karasik E, Gillard BM, Azabdaftari G, Smiraglia DJ, Foster BA.

Prostate. 2016 Mar;76(4):359-68. doi: 10.1002/pros.23127. Epub 2015 Dec 8.

25.

Perceptions of Weight and Health Practices in Hispanic Children: A Mixed-Methods Study.

Foster BA, Hale D.

Int J Pediatr. 2015;2015:761515. doi: 10.1155/2015/761515. Epub 2015 Aug 25.

26.

A randomized clinical trial of the effects of parent mentors on early childhood obesity: Study design and baseline data.

Foster BA, Aquino C, Gil M, Flores G, Hale D.

Contemp Clin Trials. 2015 Nov;45(Pt B):164-169. doi: 10.1016/j.cct.2015.08.017. Epub 2015 Sep 4.

27.

Enhancing Tabletop X-Ray Phase Contrast Imaging with Nano-Fabrication.

Miao H, Gomella AA, Harmon KJ, Bennett EE, Chedid N, Znati S, Panna A, Foster BA, Bhandarkar P, Wen H.

Sci Rep. 2015 Aug 28;5:13581. doi: 10.1038/srep13581.

28.

Cross Sectional Characterization of Factors Associated with Pediatric HIV Status Disclosure in Southern Ethiopia.

Tadesse BT, Foster BA, Berhan Y.

PLoS One. 2015 Jul 13;10(7):e0132691. doi: 10.1371/journal.pone.0132691. eCollection 2015.

29.

Treatment Interventions for Early Childhood Obesity: A Systematic Review.

Foster BA, Farragher J, Parker P, Sosa ET.

Acad Pediatr. 2015 Jul-Aug;15(4):353-61. doi: 10.1016/j.acap.2015.04.037. Review.

30.

A positive deviance approach to early childhood obesity: cross-sectional characterization of positive outliers.

Foster BA, Farragher J, Parker P, Hale DE.

Child Obes. 2015 Jun;11(3):281-8. doi: 10.1089/chi.2014.0098. Epub 2015 Apr 17.

31.

Motionless electromagnetic phase stepping versus mechanical phase stepping in x-ray phase-contrast imaging with a compact source.

Harmon KJ, Miao H, Gomella AA, Bennett EE, Foster BA, Bhandarkar P, Wen H.

Phys Med Biol. 2015 Apr 21;60(8):3031-43. doi: 10.1088/0031-9155/60/8/3031. Epub 2015 Mar 24.

PMID:
25803511
32.

Multi-Drug Resistance ABC Transporter Inhibition Enhances Murine Ventral Prostate Stem/Progenitor Cell Differentiation.

Samant MD, Jackson CM, Felix CL, Jones AJ, Goodrich DW, Foster BA, Huss WJ.

Stem Cells Dev. 2015 May 15;24(10):1236-51. doi: 10.1089/scd.2014.0293. Epub 2015 Feb 25.

33.

The Thoc1 ribonucleoprotein and prostate cancer progression.

Chinnam M, Wang Y, Zhang X, Gold DL, Khoury T, Nikitin AY, Foster BA, Li Y, Bshara W, Morrison CD, Payne Ondracek RD, Mohler JL, Goodrich DW.

J Natl Cancer Inst. 2014 Oct 8;106(11). pii: dju306. doi: 10.1093/jnci/dju306. Print 2014 Nov.

34.

Differential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancer.

Gelman IH, Peresie J, Eng KH, Foster BA.

Mol Cancer Res. 2014 Oct;12(10):1470-9. doi: 10.1158/1541-7786.MCR-13-0490-T. Epub 2014 Jul 22.

35.

Early growth inhibition is followed by increased metastatic disease with vitamin D (calcitriol) treatment in the TRAMP model of prostate cancer.

Ajibade AA, Kirk JS, Karasik E, Gillard B, Moser MT, Johnson CS, Trump DL, Foster BA.

PLoS One. 2014 Feb 26;9(2):e89555. doi: 10.1371/journal.pone.0089555. eCollection 2014.

36.

Hypotonic versus isotonic fluids in hospitalized children: a systematic review and meta-analysis.

Foster BA, Tom D, Hill V.

J Pediatr. 2014 Jul;165(1):163-169.e2. doi: 10.1016/j.jpeds.2014.01.040. Epub 2014 Feb 28. Review.

PMID:
24582105
37.

A transgenic mouse model for early prostate metastasis to lymph nodes.

Ko HK, Akakura S, Peresie J, Goodrich DW, Foster BA, Gelman IH.

Cancer Res. 2014 Feb 1;74(3):945-53. doi: 10.1158/0008-5472.CAN-13-1157. Erratum in: Cancer Res. 2014 Apr 15;74(8):2374.

38.
39.

Observational study of patient and surgeon preoperative preparation in ten companion animal clinics in Ontario, Canada.

Anderson ME, Foster BA, Weese JS.

BMC Vet Res. 2013 Oct 5;9:194. doi: 10.1186/1746-6148-9-194.

40.

Human prostate side population cells demonstrate stem cell properties in recombination with urogenital sinus mesenchyme.

Foster BA, Gangavarapu KJ, Mathew G, Azabdaftari G, Morrison CD, Miller A, Huss WJ.

PLoS One. 2013;8(1):e55062. doi: 10.1371/journal.pone.0055062. Epub 2013 Jan 31.

41.

Hidden Properties of Carbon Dots Revealed After HPLC Fractionation.

Vinci JC, Ferrer IM, Seedhouse SJ, Bourdon AK, Reynard JM, Foster BA, Bright FV, Colón LA.

J Phys Chem Lett. 2013 Jan 17;4(2):239-43. doi: 10.1021/jz301911y. Epub 2012 Dec 28.

PMID:
26283428
42.

Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α.

Riddell JR, Maier P, Sass SN, Moser MT, Foster BA, Gollnick SO.

PLoS One. 2012;7(11):e50394. doi: 10.1371/journal.pone.0050394. Epub 2012 Nov 21.

43.

Definition of molecular determinants of prostate cancer cell bone extravasation.

Barthel SR, Hays DL, Yazawa EM, Opperman M, Walley KC, Nimrichter L, Burdick MM, Gillard BM, Moser MT, Pantel K, Foster BA, Pienta KJ, Dimitroff CJ.

Cancer Res. 2013 Jan 15;73(2):942-52. doi: 10.1158/0008-5472.CAN-12-3264. Epub 2012 Nov 13.

44.

In situ vaccination with CD204 gene-silenced dendritic cell, not unmodified dendritic cell, enhances radiation therapy of prostate cancer.

Guo C, Yi H, Yu X, Zuo D, Qian J, Yang G, Foster BA, Subjeck JR, Sun X, Mikkelsen RB, Fisher PB, Wang XY.

Mol Cancer Ther. 2012 Nov;11(11):2331-41. doi: 10.1158/1535-7163.MCT-12-0164. Epub 2012 Aug 15.

45.

Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1.

Chitta KS, Paulus A, Ailawadhi S, Foster BA, Moser MT, Starostik P, Masood A, Sher T, Miller KC, Iancu DM, Conroy J, Nowak NJ, Sait SN, Personett DA, Coleman M, Furman RR, Martin P, Ansell SM, Lee K, Chanan-Khan AA.

Leuk Lymphoma. 2013 Feb;54(2):387-96. doi: 10.3109/10428194.2012.713481. Epub 2012 Aug 27.

46.

Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.

Godoy AS, Sotomayor PC, Villagran M, Yacoub R, Montecinos VP, McNerney EM, Moser M, Foster BA, Onate SA.

Biochem Biophys Res Commun. 2012 Jul 6;423(3):564-70. doi: 10.1016/j.bbrc.2012.06.005. Epub 2012 Jun 10.

PMID:
22695118
47.

A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.

Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM.

J Biol Chem. 2012 Jul 13;287(29):24832-43. doi: 10.1074/jbc.M112.370783. Epub 2012 May 31.

48.

Dietary folate deficiency blocks prostate cancer progression in the TRAMP model.

Bistulfi G, Foster BA, Karasik E, Gillard B, Miecznikowski J, Dhiman VK, Smiraglia DJ.

Cancer Prev Res (Phila). 2011 Nov;4(11):1825-34. doi: 10.1158/1940-6207.CAPR-11-0140. Epub 2011 Aug 11.

49.

Food insecurity and obesity in New York City primary care clinics.

Karnik A, Foster BA, Mayer V, Pratomo V, McKee D, Maher S, Campos G, Anderson M.

Med Care. 2011 Jul;49(7):658-61. doi: 10.1097/MLR.0b013e31820fb967.

PMID:
21430579
50.

Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature.

Riddell JR, Bshara W, Moser MT, Spernyak JA, Foster BA, Gollnick SO.

Cancer Res. 2011 Mar 1;71(5):1637-46. doi: 10.1158/0008-5472.CAN-10-3674. Epub 2011 Feb 22.

Supplemental Content

Loading ...
Support Center